How Does Resunab Differ From Other Lupus Therapies?

In this short video from Corbus Pharmaceutical Holdings Ltd, Dr. Meggan Mackay from the Hofstra Northwell School of Medicine in Hempstead, New York, tells us a little bit about how Resunab is different than other treatments for lupus.

Read how Corbus added a clinical protocol to a lupus Phase 2 trial for Resunab.

Dr. Mackay talks briefly about the effects of Resunab. It not only suppresses the proteins that cause inflammation but also encourages the growth of proteins which promote the resolution of the inflammation, and is the only drug available for lupus patients that does that. Dr. Mackay hopes that in the future Resunab will be used for lupus patients instead of corticosteroids.

Find out more about how the body’s cells are affected by lupus. 

Lupus News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.